News
-
Aclarion Added to PRISM Emerging Medical Devices Index
September 6, 2024 -
Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market
September 5, 2024 -
Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
August 29, 2024 -
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans
August 21, 2024 -
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
August 15, 2024 -
Aclarion Announces First Commercial Agreement in Michigan
August 14, 2024 -
Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK
August 13, 2024 -
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
July 9, 2024 -
Aclarion Announces Initial Payer Coverage of Nociscan by AXA throughout Greater London, UK
June 26, 2024 -
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
June 25, 2024